U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS
This repository is under review for potential modification in compliance with Administration directives.

Details

Stereochemistry ACHIRAL
Molecular Formula C14H13N3O5S
Molecular Weight 335.335
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of SULFANITRAN

SMILES

CC(=O)NC1=CC=C(C=C1)S(=O)(=O)NC2=CC=C(C=C2)[N+]([O-])=O

InChI

InChIKey=GWBPFRGXNGPPMF-UHFFFAOYSA-N
InChI=1S/C14H13N3O5S/c1-10(18)15-11-4-8-14(9-5-11)23(21,22)16-12-2-6-13(7-3-12)17(19)20/h2-9,16H,1H3,(H,15,18)

HIDE SMILES / InChI

Molecular Formula C14H13N3O5S
Molecular Weight 335.335
Charge 0
Count
MOL RATIO 1 MOL RATIO (average)
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

Sulfanitran is a sulfonamide antiinfective drug. It was approved for veterinary use as an aid in the treatment of coccidiosis caused by E. tenella, E. necatrix, and E. acervulina..

Approval Year

Targets

Primary TargetPharmacologyConditionPotency

Conditions

ConditionModalityTargetsHighest PhaseProduct
Curative
Novastat

PubMed

Sample Use Guides

In Vivo Use Guide
Poultry: conditions of use. It is used in the drinking water of chickens as follows: Amount. 374–747 milligrams of sulfanitran with 477–954 milligrams of aklomide.
Route of Administration: Oral
In Vitro Use Guide
500 uM sulfanitran stimulated the vectorial transport of saquinavir, a recently described MRP2 substrate, across polarized MDCKII monolayers demonstrating that it also stimulates MRP2 in intact cells.
Substance Class Chemical
Record UNII
QT35T5T35Q
Record Status Validated (UNII)
Record Version